BioSpace News Archive

Annexon, Inc. today outlined anticipated upcoming milestones across its portfolio of complement therapies and reported fourth quarter and full year 2022 financial results.

Financing will support future studies of lead program BCA101, currently in Phase 1/1b clinical development in head and neck cancer, and pipeline growth.

Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the Oppenheimer 33rd Annual Healthcare Conference.

Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS) disorders, today reported financial results for the fourth quarter and full-year ended December 31, 2022 and provided recent business highlights.

MediWound Ltd., a fully integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for tissue repair and regeneration, announced the appointment of Barry Wolfenson as Executive Vice President of Strategy & Corporate Development.

BioLineRx Ltd. today announced a collaboration with Washington University School of Medicine in St. Louis to advance a Phase 1 clinical trial that will evaluate the safety and feasibility of the Company’s lead clinical candidate motixafortide to mobilize CD34+ hematopoietic stem cells (HSCs) for gene therapies in sickle cell disease (SCD), one of the most common genetic diseases globally.

Lavie Bio Ltd. today announced in that its management will be sponsoring and participating at the World Agri-Tech Conference in San Francisco, taking place between March 14-15, 2023.

Kezar Life Sciences, Inc. today announced that it will host a virtual Research and Development (R&D) Day on Wednesday, March 22, 2023 at 4:30 pm ET/1:30 pm PT.

After acquiring substantially all assets of BERG, LLC at the beginning of 2023, BPGbio, Inc, a leading AI-powered biopharma with a mission to reimagine biology for humanity, announced today the appointment of four key executives.

Corentec, a forward-thinking medical device company focused on developing solutions for the orthopedic market, will be showcasing its latest products at the American Academy of Orthopedic Surgeons 2023 Conference from March 7 to March 11, 2023, in the Venetian Expo booth # 5027.